Guardian Capital (Canada)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.2K Hold
14,700
– – ﹤0.01% 173
2026
Q1
$73.8K Sell
14,700
-3,600
-20% -$321K ﹤0.01% 172
2025
Q4
$97.9K Sell
18,300
-100
-0.5% -$7.84K ﹤0.01% 164
2025
Q3
$173K Hold
18,400
– – 0.01% 147
2025
Q2
$78.8K Hold
18,400
– – ﹤0.01% 148
2025
Q1
$93.5K Hold
18,400
– – ﹤0.01% 140
2024
Q4
$77.6K Buy
+18,400
New +$1.76M ﹤0.01% 131

Other funds holding CL

Guardian Capital (Canada)'s CL Position: Q2 2026 in Review

Guardian Capital (Canada) reduced its Colgate-Palmolive (CL) stake by 15% in Q2 2026, selling an estimated $621K and leaving 39,800 shares worth $3.65M. The position accounts for 0.09% of the portfolio, ranked #101.

Guardian Capital (Canada) first reported a position in CL in Q4 2014 and has held it in 38 quarters since. The position peaked at $7.13M in Q3 2025. 2,027 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Guardian Capital (Canada) held 39,800 shares of Colgate-Palmolive worth $3.65M as of Q2 2026.
  • Guardian Capital (Canada) sold 7,100 Colgate-Palmolive shares in Q2 2026, an estimated $621K.
  • Colgate-Palmolive made up 0.09% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #101 holding.
  • Guardian Capital (Canada) first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 38 quarters since.
  • Guardian Capital (Canada)'s Colgate-Palmolive position peaked at $7.13M in Q3 2025.
  • 2,027 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.